Injeq was founded when a group of experts in the fields of technology and medicine identified a solution for a well-known medical need – to make lumbar punctures safer and more precise. The vision of a smart needle was further developed to a fully-formed idea, and from there to clinical research at neonatal intensive care units and pediatric oncology departments.
Now Injeq has a clinically proven product soon ready for the market, based on unique, tried and tested technology. Injeq IQ-Tip® spinal needle is the leading product in its field, offering safe and smooth procedures through real-time information.
Our staff consists of professionals with expertise in a wide range of fields, including medical research, signal processing, clinical research, European regulation, and various areas of production, quality assurance and corporate management.
We have an active corporate board, that includes the original developers of the innovation complemented with external experts. The board members support the operational organization and participate actively in company development.
The main benefits of our smart needle – Precision, Care and Confidence – are present in everything we do and what we want to offer our clients.
Injeq IQ-Tip® products are designed and manufactured to meet the requirements of the European Medical Device Regulation (MDR 2017/745). As a medical device manufacturer, Injeq applies standard ISO 13485:2016 in its quality system. IQ-Tip® needle received CE approval on December 21, 2021 and the innovative Injeq IQ-Tip® system is ready for sales to the European market.
